garcinol has been researched along with Pancreatic Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, J; Fu, W; Huang, Q; Phang, Y; Tan, J; Wang, X; Wu, R; Xu, H; Zhang, L; Zheng, C | 1 |
| Akhtar, S; David, D; Geamanu, A; Goja, A; Gupta, SV; Razalli, NH; Saadat, N; Shen, Y | 1 |
| Chiou, JF; Hsu, C; Huang, CC; Huang, YJ; Kuo, CC; Lee, WH; Lin, CM; Ting, LL; Wei, L; Wu, ATH | 1 |
| Ahmad, A; Dandawate, P; Deshpande, J; Oswal, N; Padhye, S; Rub, RA; Sarkar, FH; Swamy, KV | 1 |
| Gupta, SV; Parasramka, MA | 1 |
| Ahmad, A; Ali, R; Banerjee, S; Bao, B; Kong, D; Maitah, MY; Padhye, S; Sarkar, FH; Wang, Z; Wojewoda, C | 1 |
| Ali, S; Banerjee, S; Deryavoush, T; Gupta, S; Parasramka, MA; Sarkar, FH | 1 |
7 other study(ies) available for garcinol and Pancreatic Neoplasms
| Article | Year |
|---|---|
Garcinol and its analogues: Synthesis, cytotoxic activity and mechanistic investigation.
Topics: Antineoplastic Agents; Apoptosis; Benzophenones; Humans; Pancreatic Neoplasms; Signal Transduction; Terpenes | 2023 |
Dietary Garcinol Arrests Pancreatic Cancer in p53 and K-ras Conditional Mutant Mouse Model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Deoxycytidine; Dietary Supplements; Gemcitabine; Genes, p53; Genes, ras; Humans; Magnetic Resonance Imaging; Male; Mice, Transgenic; Neoplasms, Experimental; Pancreatic Neoplasms; S100 Calcium Binding Protein beta Subunit; Smad4 Protein; Survival Rate; Terpenes | 2018 |
Garcinol downregulates Notch1 signaling via modulating miR-200c and suppresses oncogenic properties of PANC-1 cancer stem-like cells.
Topics: Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; MicroRNAs; Neoplasm Proteins; Neoplastic Stem Cells; Pancreatic Neoplasms; Receptor, Notch1; Signal Transduction; Terpenes | 2017 |
Fluorinated 2'-hydroxychalcones as garcinol analogs with enhanced antioxidant and anticancer activities.
Topics: Antineoplastic Agents; Antioxidants; Binding Sites; Cell Line, Tumor; Chalcones; Computer Simulation; Cyclooxygenase 2; Halogenation; Humans; Pancreatic Neoplasms; Protein Structure, Tertiary; Superoxide Dismutase; Terpenes | 2010 |
Garcinol inhibits cell proliferation and promotes apoptosis in pancreatic adenocarcinoma cells.
Topics: Adenocarcinoma; Analysis of Variance; Apoptosis; Blotting, Western; Caspase 3; Caspase 9; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dinoprostone; Genes, ras; Humans; Interleukin-8; Matrix Metalloproteinase 9; NF-kappa B; Pancreatic Neoplasms; Signal Transduction; Terpenes; Vascular Endothelial Growth Factor A | 2011 |
Garcinol-induced apoptosis in prostate and pancreatic cancer cells is mediated by NF- kappaB signaling.
Topics: Apoptosis; Blotting, Western; Cell Line, Tumor; Electrophoretic Mobility Shift Assay; Enzyme-Linked Immunosorbent Assay; Humans; Male; NF-kappa B; Pancreatic Neoplasms; Prostatic Neoplasms; Signal Transduction; Terpenes | 2011 |
Garcinol sensitizes human pancreatic adenocarcinoma cells to gemcitabine in association with microRNA signatures.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Blotting, Western; Caspases; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Gemcitabine; Humans; Interleukin-8; Matrix Metalloproteinase 9; Microarray Analysis; MicroRNAs; NF-kappa B; Pancreatic Neoplasms; Phenotype; Signal Transduction; Terpenes; Vascular Endothelial Growth Factor A; Wound Healing | 2013 |